Literature DB >> 2176973

Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation.

F Gieseler1, F Boege, M Clark.   

Abstract

The inhibition of differentiation and persistence of proliferation in cell transformation is probably not only caused by the mutation of single genes. An additional mechanism of transcriptional control, not only of single genes but of gene programs, is possibly the alteration of the topoisomerases. These enzymes regulate the conformation of DNA by twisting and unwinding the double strands. As has been shown previously, only the genes located in relaxed DNA areas are transcribed and, therefore, the topoisomerases can be described as a gene regulation device. We present the hypothesis that topoisomerase II action is not only altered in, but also necessary for, HL-60 granulocytic cell differentiation. Thus, alteration of topoisomerases may well be a molecular mechanism of cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176973      PMCID: PMC1567985          DOI: 10.1289/ehp.9088183

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  8 in total

1.  Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylation.

Authors:  F Gieseler; P Meyer; D Schiffmann; K Wilms
Journal:  Blut       Date:  1989-03

2.  Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

Authors:  K B Tan; M R Mattern; R A Boyce; P S Schein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Eukaryotic topoisomerase II. Characterization of enzyme turnover.

Authors:  N Osheroff
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

4.  In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene.

Authors:  J F Riou; E Multon; M J Vilarem; C J Larsen; G Riou
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

Review 5.  Topoisomerases in human disease.

Authors:  R J Epstein
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

Review 6.  Topoisomerase II as a target of anticancer drug action in mammalian cells.

Authors:  K W Kohn; Y Pommier; D Kerrigan; J Markovits; J M Covey
Journal:  NCI Monogr       Date:  1987

7.  ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells.

Authors:  F J Castora; W G Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  DNA topoisomerase II cleaves at specific sites in the 5' flanking region of c-fos proto-oncogenes in vitro.

Authors:  M K Darby; R E Herrera; H P Vosberg; A Nordheim
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.